|
LSM5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.087000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.476600E-01 |
| Normal-vs-Stage2 |
4.646600E-01 |
| Normal-vs-Stage3 |
9.962800E-01 |
| Normal-vs-Stage4 |
2.589600E-01 |
| Stage1-vs-Stage2 |
2.231600E-01 |
| Stage1-vs-Stage3 |
4.496400E-01 |
| Stage1-vs-Stage4 |
1.948080E-02 |
| Stage2-vs-Stage3 |
4.658600E-01 |
| Stage2-vs-Stage4 |
9.203000E-01 |
| Stage3-vs-Stage4 |
3.470200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.796000E-01 |
| Normal-vs-AfricanAmerican |
4.637800E-01 |
| Normal-vs-Asian |
3.441800E-01 |
| Caucasian-vs-AfricanAmerican |
3.557200E-01 |
| Caucasian-vs-Asian |
5.219800E-01 |
| AfricanAmerican-vs-Asian |
4.875000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.302000E-01 |
| Normal-vs-Female |
5.227600E-01 |
| Male-vs-Female |
2.857800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.119200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.293400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.370200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.228000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.891600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.828800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.478000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.452600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.054600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.103000E-01 |
| Normal-vs-Grade 2 |
8.930600E-01 |
| Normal-vs-Grade 3 |
6.019200E-01 |
| Normal-vs-Grade 4 |
8.556200E-01 |
| Grade 1-vs-Grade 2 |
1.581760E-01 |
| Grade 1-vs-Grade 3 |
3.512200E-01 |
| Grade 1-vs-Grade 4 |
2.979400E-01 |
| Grade 2-vs-Grade 3 |
4.906400E-01 |
| Grade 2-vs-Grade 4 |
9.494000E-01 |
| Grade 3-vs-Grade 4 |
5.166400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.630200E-01 |
| Normal-vs-ccB subtype |
9.784600E-01 |
| ccA subtype-vs-ccB subtype |
6.096800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.827000E-01 |
| Normal-vs-N1 |
3.483200E-01 |
| N0-vs-N1 |
4.799200E-01 |
|
|
